Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children
Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children: A Randomized Controlled Trial
Seoul National University Hospital
96 participants
Apr 1, 2026
INTERVENTIONAL
Conditions
Summary
This prospective randomized controlled trial aims to compare basilic vein and cephalic vein approaches for midline catheter placement in pediatric patients undergoing general anesthesia. Participants aged 2 to 17 years who require midline catheter insertion will be randomly assigned 1:1 to either the basilic vein group or the cephalic vein group. The primary outcome is the clinical blood sampling success rate during the catheter dwell period, defined as successful aspiration of ≥2 mL of blood through the midline catheter at least once without additional venipuncture. Secondary outcomes include operator-rated difficulty, number of puncture attempts, first attempt cannulation success rate, vein diameter and depth, catheter dwell time, catheter-related complications, and patient satisfaction. A total of 96 participants (48 per arm) will be enrolled at Seoul National University Children's Hospital.
Eligibility
Inclusion Criteria2
- Age 2-17 years undergoing general anesthesia
- Midline catheter placement deemed necessary by attending anesthesiologist (≥1 of: expected ≥2 postop blood draws; expected blood loss ≥40% EBV; continuous antibiotic therapy; hospitalization ≥7 days; surgical team request)
Exclusion Criteria4
- Need for central venous catheter per surgical team
- Coagulopathy
- History of severe thrombosis
- Other investigator-determined ineligibility
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Midline catheter placement via basilic vein under ultrasound guidance
Midline catheter placement via cephalic vein under ultrasound guidance
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07509359